NL-OMON39370招募中不适用
Effectiveness of Pivotal Response Treatment: Plasticity of emotion regulation in young children. - Plasticity of emotion regulation in young children.
niversiteit Leiden0 个研究点目标入组 90 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 90
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 2 至 11（—）
入选标准
- •General inclusion criteria include age between 3 and 6 years old, voluntary participation, Dutch or English speaking and a signed informed consent from parents or official caretakers. For the ASD groups additional inclusion criteria are an independent clinical diagnosis of autism according to the DSM-IV criteria that will be confirmed with an ADI-R and ADOS at the start of this study, intelligence quotient above 50, no neurological condition (i.e. epilepsy), severe head trauma with loss of consciousness and / or metabolic diseases.
排除标准
- •General exclusion criteria are:
- •- IQ < 50
- •- Lack of comprehension of the Duch or English language by parents and/ or child
- •- History of neurological conditions or head injury with loss of consiousness for children, and/ or metabolic diseases
研究者
相似试验
进行中（未招募）
1 期
A Study of LY3844583 in Healthy Participants and Participants With Atopic DermatitisJPRN-jRCT2031220745Wakayama Naohiko86
进行中（未招募）
不适用
A Phase III, Multicentre, Randomised, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Subcutaneous Bioresorbable CUV1647 Implants in Patients with Erythropoietic Protoporphyria (EPP) - Multicentre Phase III EPP StudyEUCTR2007-000636-13-DEClinuvel Pharmaceuticals Limited80
进行中（未招募）
1 期
A Phase III, Multicentre, Randomised, Placebo-Controlled, Double Blind Study of the Incidence of Recurring Pulmonary Exacerbations in Cystic Fibrosis Patients using Two Different Doses of Inhaled Nacystelyn®MedDRA version: 12.1Level: PTClassification code 10011762Term: Cystic fibrosisCystic fibrosisEUCTR2010-018454-13-DKaboratoires SMB S.A.552
进行中（未招募）
1 期
A Phase III, Multicentre, Randomised, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Subcutaneous Bioresorbable CUV1647 Implants in Patients with Erythropoietic Protoporphyria (EPP) - Multicentre Phase III EPP StudyEUCTR2007-000636-13-FRClinuvel Pharmaceuticals Limited80
进行中（未招募）
不适用
A Phase III, Multicentre, Randomised, Placebo-Controlled, Double Blind Study of the Incidence of Recurring Pulmonary Exacerbations in Cystic Fibrosis Patients using Two Different Doses of Inhaled Nacystelyn - NDMedDRA version: 9.1Level: PTClassification code 10011762Cystic fibrosisEUCTR2010-018454-13-ITABORATOIRES SMB S.A.552